Oct 2026· Exploration of Cardiology· 0 citations· 34 references
TL;DR
This is one of the first studies to identify an approximate mortality crossover point between CSM and BC-specific mortality at about 8 years (97 months) in women aged 70–85, providing a clinically relevant, exploratory time point for increased cardiovascular monitoring in this high-risk population.
Abstract
Aim: Cardiovascular disease (CVD) is the most common non-cancer cause of death in breast cancer (BC) survivors, yet the age-specific point at which CVD deaths overtake BC deaths, and its early indicators, remain unknown. This study aimed to establish this time point and identify factors associated with cardiovascular-specific mortality (CSM) in early-stage BC. Methods: We analyzed 255,731 women diagnosed with stage I–III BC (2010–2020) from the Surveillance, Epidemiology, and End Results (SEER) 17 registries. CSM was compared with the general United States (US) female population using standardized mortality ratio (SMR) via Centers for Disease Control and Prevention’s Wide-ranging Online Data for Epidemiologic Research (CDC WONDER). Competing-risk methods estimated cumulative incidence, and Fine-Gray regression identified factors associated with CSM after adjustment for measured covariates. Results: Upon age standardization, the overall risk of CSM was modestly higher among BC patients than in the general female population [SMR = 1.16, 95% confidence intervals (CI): 1.13–1.19, P < 0.001], with marked heterogeneity by age; the relative excess was greatest in women aged < 50 (SMR = 2.894) and attenuated in older strata (50–59, SMR = 1.138; 60–69, SMR = 1.208; 70–85, SMR = 1.128). Cumulative CSM reached 2.53% at 84 months (7 years). Within the oldest cohort (70–85 years), cumulative CSM crossed above BC-specific mortality later, at approximately 8 years (97 months; 95% CI 91–101) [sub-distribution hazard ratio (SHR) = 19.37; 70–85 vs. 18–49], followed by unmarried status (1.59), Black race (1.37), advanced tumor (T4, 1.60) and nodal stage (N3, 1.34). Chemotherapy and radiotherapy were associated with lower CSM (SHR = 0.59 and 0.64); given SEER’s lack of treatment data, these likely reflect selection bias and residual confounding rather than protection. Conclusions: This is one of the first studies to identify an approximate mortality crossover point between CSM and BC-specific mortality at about 8 years (97 months) in women aged 70–85, providing a clinically relevant, exploratory time point for increased cardiovascular monitoring in this high-risk population.
Relevance: Breast cancer is the most common malignancy in women and one of the leading causes of cancer-related mortality.
Despite the availability of clinical and biological prognostic factors, developing simple, clinically applicable risk stratification tools
remains an important challenge.
The study aimed to iden...
I. Novikov, S. Yessentayeva, V. Makarov et al.· Eurasian Journal of Oncology...· 0 citations
The findings support an individualized approach weighing risk of BC death against competing mortality, emphasizing comorbidity management and CV risk reduction in patients most likely to die of non-cancer causes.
C. Wabl, Morah Brown, Shi-Yun Zhu et al.· JCO Oncology Practice· 0 citations
BCa and inherited genetic susceptibility jointly contribute to increased risk of multiple common diseases, supporting the integration of genetic risk stratification into survivorship care.
Annabelle Ashworth, Zhu-Qing Shi, Huy Tran et al.· JNCI Cancer Spectrum· 0 citations
Cancer remains a leading cause of mortality globally, while hypertension is the primary contributor to cardiovascular disease and premature death. These conditions frequently coexist; hypertension may precede cancer due to shared risk factors or arise during or after cancer treatment, partly as a result of the hyperten...
Bahaa Mali, Ali Mali, Alaa Mali et al.· Scientific Reports· 0 citations
In PC survivors, uncontrolled diabetes is independently associated with MACE, highlighting the importance of achieving and maintaining glycemic control in patients with PC.
E. Pallares, E. Muslera, M. Perez-Nuques et al.· European Heart Journal· 0 citations
Hypertension diagnosed after cancer diagnosis was associated with a notable proportion of all-cause mortality among older adult cancer survivors, with variation by cancer site and race and ethnicity.
Victoria M. Telles, Anne-Michelle Noone, Emily S. Tonorezos et al.· JCO Oncology Practice· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.